Dongkoo Bio&Pharma Co (XKRX:006620) Cash per Share: ₩1,526.79 (As of Mar. 2026)


XKRX:006620 Dongkoo Bio&Pharma Co Ltd XKRX:006620
77 GF Score
Price ₩3,665.00
GF Value ₩5,714.19
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Dongkoo Bio&Pharma Co Cash per Share?

Dongkoo Bio&Pharma Co XKRX:006620 -4.81% 77 Cash per Share is ₩1,526.79 as of Mar. 2026. GuruFocus rates XKRX:006620 with a GF Score™ of 77/100 and a GF Value™ of ₩5,714.19 (Possible Value Trap). The stock has 9 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Dongkoo Bio&Pharma Co's Cash per Share for the quarter that ended in Mar. 2026 was ₩1,526.79.

Dongkoo Bio&Pharma Co  (XKRX:006620) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Dongkoo Bio&Pharma Co Cash per Share Related Terms

Dongkoo Bio&Pharma Co Cash per Share Historical Data

* Premium members only.

The historical data trend for Dongkoo Bio&Pharma Co's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dongkoo Bio&Pharma Co Cash per Share Chart

Dongkoo Bio&Pharma Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,144.78 1,271.94 829.39 1,340.52 1,300.37

Dongkoo Bio&Pharma Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,466.26 608.72 833.69 1,300.37 1,526.79
XKRX:006620
77GF Score
Dongkoo Bio&Pharma Co Ltd XKRX:006620
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dongkoo Bio&Pharma Co Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Dongkoo Bio&Pharma Co's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=35164.538/27
=1,300.37

Dongkoo Bio&Pharma Co's Cash per Share for the quarter that ended in Mar. 2026 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=41287.313/27
=1,526.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of ₩1,526.79 mean?
Dongkoo Bio&Pharma Co (XKRX:006620) has a Cash per Share of ₩1,526.79 as of Mar. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Dongkoo Bio&Pharma Co and its competitors.
Is Dongkoo Bio&Pharma Co's Cash per Share too high?
Dongkoo Bio&Pharma Co's current Cash per Share is ₩1,526.79. Overall, Dongkoo Bio&Pharma Co has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dongkoo Bio&Pharma Co's Cash per Share compare to ZTS?
Dongkoo Bio&Pharma Co's Cash per Share of ₩1,526.79 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Drug Manufacturers company?
A good Cash per Share depends on the Drug Manufacturers industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Dongkoo Bio&Pharma Co and its competitors. Dongkoo Bio&Pharma Co's current Cash per Share is ₩1,526.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dongkoo Bio&Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Dongkoo Bio&Pharma Co (XKRX:006620) is currently considered Possible Value Trap. The stock's GF Value™ is ₩5,714.19, compared to a current price of ₩3,665.00 — trading 35.9% below its estimated fair value. The current Cash per Share is ₩1,526.79. Dongkoo Bio&Pharma Co's overall GF Score™ is 77/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For Dongkoo Bio&Pharma Co (XKRX:006620), the current Cash per Share is ₩1,526.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dongkoo Bio&Pharma Co (XKRX:006620) Overvalued in 2026?

Based on GuruFocus' analysis, Dongkoo Bio&Pharma Co stock appears to be undervalued. The current stock price of ₩3,665.00 is trading 35.9% below its estimated GF Value™ of ₩5,714.19. GuruFocus considers Dongkoo Bio&Pharma Co to be Possible Value Trap.

Key valuation signals for XKRX:006620:

  • Cash per Share: ₩1,526.79
  • GF Value™: ₩5,714.19 vs. price of ₩3,665.00 (35.9% below fair value)
  • GF Score™: 77/100 with 9 warning signs

No single metric tells the full story. See the XKRX:006620 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dongkoo Bio&Pharma Co Business Description

Address B-14F, M State Building, 114, Beobwonro, Songpagu, Seoul, KOR, 05836
Dongkoo Bio&Pharma Co Ltd is engaged in the research, development, manufacture, and sale of pharmaceuticals products. The company provides products for digestants, other analgesics and antipyretics, nonsteroidal anti-inflammatory drugs, oral hypoglycemic agents, antiplatelet agents, antihistamines and anti-allergic, and decongestants and nasal sprays. It offers its products in multiple forms such as capsules, tablet, powder, granule, and liquid. The company exports its products to various countries including Vietnam, New Zealand, Thailand, Hong Kong and Singapore.
77GF Score

Get the complete analysis for XKRX:006620

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩3,665.00
Price
₩5,714.19
GF Value